Blog
RSS FeedPosted by Michael Wonder on 20 Nov 2019
Top GOP senator: drug pricing action unlikely before end of year
19 November 2019 - Senator John Thune, the Senate’s No. 2 Republican, said Tuesday that it is unlikely the Senate ...
Posted by Michael Wonder on 20 Nov 2019
Auckland widow's wish to give away leftover cancer medication illegal under Medicines Act
20 November 2019 - An Auckland widow who spoke out about New Zealand's drug wastage after her husband's death will ...
Posted by Michael Wonder on 19 Nov 2019
In a rare political move, prominent biotech venture capitalists speak out against Pelosi’s drug pricing bill
18 November 2019 - A group of top biotech venture capitalists are issuing a stark warning to Congress: They won’t ...
Posted by Michael Wonder on 19 Nov 2019
Epilepsy sufferer says victims of PHARMAC drug switch should be compensated
19 November 2019 - An epilepsy sufferer who urged others to boycott the Government's change in anti-epileptic drug medication is ...
Posted by Michael Wonder on 19 Nov 2019
Elizabeth Warren says ‘Medicare for All’ rollout process will take 3 years
16 November 2019 — Elizabeth Warren announced Friday that she would expand public health insurance during her first 100 days ...
Posted by Michael Wonder on 19 Nov 2019
Drug cost legislation gets a push from White House
18 November 2019 - The White House is ramping up its push to get a bill through Congress that curbs ...
Posted by Michael Wonder on 18 Nov 2019
Group launches seven-figure ad buy boosting vulnerable Democrats on drug prices
18 November 2019 - A Democratic group is launching $2 million in new digital ads highlighting vulnerable House Democrats’ efforts ...
Posted by Michael Wonder on 18 Nov 2019
Statement from Sarah Yim, acting director of the Office of Therapeutic Biologics and Biosimilars in the FDA’s Center for Drug Evaluation and Research, on FDA’s continued progress facilitating competition in the biologic marketplace with approval of 25th biosimilar product
15 November 2019 - Biological products play an increasingly central role in modern medicine, offering treatments for many serious illnesses. ...
Posted by Michael Wonder on 16 Nov 2019
Labour will exclude the NHS and medicines from trade deals with the US
17 November 2019 - Donald Trump wants the big US pharmaceutical companies to get its hands on our public services – ...
Posted by Michael Wonder on 16 Nov 2019
Booker and Sanders propose a new federal agency to set drug prices
15 November 2019 - Senators Cory Booker and Bernie Sanders are pushing for the creation of a new federal agency ...
Posted by Michael Wonder on 15 Nov 2019
Dutch authorities hand over final building to EMA in Amsterdam
15 November 2019 - Today, the Dutch authorities have handed over to EMA its newly built tailor-made premises, located in ...
Posted by Michael Wonder on 15 Nov 2019
PHARMAC backs down on epilepsy drug brand switch
15 November 2019 - PHARMAC has backed down on a controversial drug brand switch affecting patients with epilepsy and mental ...
Posted by Michael Wonder on 14 Nov 2019
Researchers call on FDA to rethink guidance allowing use of surrogate outcomes
13 November 2019 - The US FDA needs to reconsider its use of surrogate outcomes in some guidance documents on ...
Posted by Michael Wonder on 14 Nov 2019
To drive down insulin prices, WHO will certify generic versions
13 November 2019 - About 80 million people with diabetes around the world need the hormone, and half of them can’t ...
Posted by Michael Wonder on 14 Nov 2019
Drug makers fight Trump appellate bid to restore rule exposing drug prices in TV ads
14 November 2019 - A Trump administration requirement that drug companies include their products’ list prices in TV ads is ...